Related Experiment Video
Updated: May 11, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
Evaluating the Implementation Success of an Intensity-Adapted Guideline for Pediatric Acute Myeloid Leukemia in
Noel Mwango1,2,3, Grace Chirwa1,2,3, Dennis Phalula4
1Baylor College of Medicine Children's Foundation, Lilongwe, Malawi.
Insights
This study evaluates the International Society of Paediatric Oncology
Area of Science:
- Pediatric Oncology
- Implementation Science
- Hematology
Background:
- Acute myeloid leukemia (AML) presents significant treatment challenges in low-resource settings.
- The International Society of Paediatric Oncology (SIOP) developed an adapted AML practice guideline in 2019 to improve outcomes.
- There is a need to evaluate the effectiveness of adapted guidelines in resource-limited environments.
Purpose of the Study:
- To present the protocol for an observational-implementation study evaluating the SIOP AML guideline in Malawi.
- To propose hybrid effectiveness-implementation designs for evaluating pediatric hematology-oncology interventions in low-resource settings.
- To generate evidence for adopting adapted treatment strategies in resource-limited contexts.
Main Methods:
- Observational-implementation study design.
- Evaluation of the SIOP adapted AML practice guideline.
- Application of hybrid effectiveness-implementation designs.
Main Results:
- The study protocol is presented for evaluating the SIOP AML guideline in Malawi.
- Hybrid designs are proposed as a method for evaluating adapted treatment strategies.
- This approach is adaptable to various pediatric hematology-oncology diseases and contexts.
Conclusions:
- The proposed hybrid designs offer a novel approach for evaluating interventions in low-resource settings.
- This study aims to inform the adoption of adapted treatment strategies for pediatric AML.
- The methodology can be applied broadly to pediatric hematology-oncology in resource-limited areas.
Abstract:
Acute myeloid leukemia (AML) is most often incurable in low-resource settings. To address this challenge, the International Society of Paediatric Oncology (SIOP) developed an intensity-adapted AML practice guideline in 2019. Here, we present the protocol of an observational-implementation study evaluating the SIOP guideline in Malawi. The purpose of this manuscript is to present a novel application of hybrid effectiveness-implementation designs adaptable to a wide spectrum of pediatric hematology-oncology diseases and contexts. Here, we propose hybrid designs as an option for teams in low-resource settings to evaluate current practice and generate much-needed evidence to inform adoption decisions regarding adapted treatment strategies.
More Related Videos
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
07:38Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025